Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

UPDATE: U.S. Treasury Secretary Announces Extended Tax Season

Client Alert
March 20, 2020

In a move for further relief for taxpayers, U.S. Treasury Secretary, Steve Mnuchin, has announced the April 15, 2020 filing deadline has been extended.

What It Is

The relief expands on the previous payment relief granted to taxpayers who have income tax payments due April 15, 2020. Now, in addition to a delay in payment, taxpayers will also not be required to file their returns until July 15, 2020. This extension is automatic and does not require the filing of the usual paperwork to obtain an extension. HOWEVER, taxpayers who wish to have the normal 6-month extension for filing their return MUST file the customary extension requests (Form 4868 or 7004) by the April 15, 2020 deadline.

State of Ohio

At this time, the State of Ohio has not issued any formal statement about extending either the due date or payment date for Ohio income taxes.  Ohio officials have said, they will “monitor IRS guidance as released” but have not committed to adopting the same deadlines and/or extensions. The Ohio Society of Certified Public Accountants has written a second letter to the governor in light of the previous payment relief granted by the IRS requesting that an extension be put in place and we are currently awaiting a response. Cities also have not made any pronouncements as their due date is tied to the State of Ohio due date.

Other States

Some other states have released guidance as to relief that they are granting taxpayers. The most up-to-date information for this is available on the American Institute of Certified Public Accountants website https://www.aicpa.org/content/dam/aicpa/advocacy/tax/downloadabledocuments/coronavirus-state-filing-relief.pdf

This information is all based on a tweet issued by Mnuchin today. No formal guidance or announcements have come from the IRS at this time. We will continue to update you on any changes as guidance becomes available.

Priscilla GrantIRSTax DeadlineFiling DateIRS Extensioncoronavirus
Client Alert

USCIS Policy Change Impacting Work Authorization: Advisory for Employers and Human Resources

December 8, 2025USCIS has issued a policy memorandum pausing immigration benefit processing for individuals from 19 high-risk countries and requiring a re-review of certain previously approved cases. This change may affect work authorization, employment verification, and workforce stability. Employers and HR teams should review impacted employees and update compliance procedures.Client Alert

CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule with Key Payment and Telehealth Updates

December 4, 2025CMS issued the CY 2026 Medicare Physician Fee Schedule Final Rule on October 31, 2025, with changes effective January 1, 2026. The Final Rule includes increases to the conversion factor, a new efficiency adjustment, updates to practice expense methodology, permanent telehealth policy changes, revised payment for skin substitutes, expanded rules for Part B drugs and biologicals, enhanced policies for Rural Health Clinics and Federally Qualified Health Centers, and new care management and behavioral health services.Client Alert

Ohio Department of Medicaid Updates: Key Changes to Physician Reimbursement Rates in Early Parenthood

December 3, 2025The Ohio Department of Medicaid has proposed amending Ohio Administrative Code Rule related to covered Medicaid reimbursements for physicians. Beginning on January 1, 2026, they are proposing an increase to rates for prenatal care, childbirth, and infant care and provider visits.Client Alert

Name, Image, and Likeness Agreements in Healthcare

November 14, 2025For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.Client Alert

Compounding GLP-1 Drugs - Recent Updates

November 13, 2025Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.
Older posts